Filing Details
- Accession Number:
- 0001628280-24-040022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-10 16:06:01
- Reporting Period:
- 2024-09-06
- Accepted Time:
- 2024-09-10 16:06:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796960 | M.d. Martina Flammer | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-06 | 36,555 | $18.95 | 142,689 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-09-06 | 25,740 | $26.46 | 168,429 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-09-06 | 18,874 | $23.66 | 187,303 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-09-06 | 34,280 | $26.43 | 221,583 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-09-06 | 14,130 | $23.75 | 235,713 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-09-06 | 19,423 | $17.07 | 255,136 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-09-06 | 76,455 | $70.90 | 178,681 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-06 | 63,483 | $71.43 | 115,198 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-06 | 9,064 | $72.61 | 106,134 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 36,555 | $0.00 | 36,555 | $18.95 |
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 25,740 | $0.00 | 25,740 | $26.46 |
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 18,874 | $0.00 | 18,874 | $23.66 |
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 34,280 | $0.00 | 34,280 | $26.43 |
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 14,130 | $0.00 | 14,130 | $23.75 |
Common Stock | Stock Option (right to buy) | Disposition | 2024-09-06 | 19,423 | $0.00 | 19,423 | $17.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
109,665 | 2033-05-11 | No | 4 | M | Direct | |
42,900 | 2031-05-12 | No | 4 | M | Direct | |
0 | 2030-01-02 | No | 4 | M | Direct | |
34,280 | 2032-01-06 | No | 4 | M | Direct | |
0 | 2030-01-03 | No | 4 | M | Direct | |
84,167 | 2032-05-11 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 76,455 shares sold at prices ranging from $70.20 to $71.20 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 63,483 shares sold at prices ranging from $71.21 to $72.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 9,064 shares sold at prices ranging from $72.23 to $73.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.